These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 24267127)

  • 1. [Multicenter investigation of therapeutic status of children with IgA nephropathy in China].
    Working Group for National Survey on Status of Diagnosis and Treatment of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2013 Jul; 51(7):486-90. PubMed ID: 24267127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
    ; Jiang XY
    Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
    Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
    Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
    Vaz de Castro PAS; Bitencourt L; Pereira BWS; Lima AQR; Hermida HS; Moreira Neto CR; Mestriner MD; Simões E Silva AC
    Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multicenter study on present status of diagnosis and treatment of steroid-resistant nephrotic syndrome in children].
    Subspecialty Group Of Nephrology, The Society Of Pediatrics Chinese Medical Association
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):483-7. PubMed ID: 25224050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy.
    Yang Y; Ohta K; Shimizu M; Nakai A; Kasahara Y; Yachie A; Koizumi S
    Clin Nephrol; 2005 Jul; 64(1):35-40. PubMed ID: 16047643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcome of IgA nephropathy in children from one single center experience.
    Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
    BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M; Małdyk J; Pańczyk-Tomaszewska M; Turczyn A; Cichoń-Kawa K; Rybi-Szumińska A; Wasilewska A; Firszt-Adamczyk A; Stankiewicz R; Bieniaś B; Zajączkowska M; Gadomska-Prokop K; Grenda R; Miklaszewska M; Pietrzyk J; Pukajło-Marczyk ; Zwolińska D; Szczepańska M; Demkow U; Roszkowska-Blaim M
    Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of concomitant nephrotic IgA nephropathy and minimal change disease in children.
    Shen H; Gu W; Mao J; Zhu X; Jin X; Fu H; Liu A; Shu Q; Du L
    Nephron; 2015; 130(1):21-8. PubMed ID: 25924689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.
    Jiang XY; Mo Y; Sun LZ; Yue ZH; Chen SM; Wu W
    Clin Nephrol; 2009 Jun; 71(6):625-31. PubMed ID: 19473630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of hemolytic uremic syndrome after acute stage].
    Ye LY; Yu ZH; Huang ZX; Chen XM; Ren RN; Chen GM; Wang CF; Xia GZ; Huang J; Wang FJ
    Zhonghua Er Ke Za Zhi; 2006 Mar; 44(3):206-9. PubMed ID: 16624060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Additive antiproteinuric effect of angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor in patients with chronic glomerulonephritis].
    Iimura O; Kusano E; Tanba K; Yanagiba S; Amemiya M; Ando Y; Honma S; Muto S; Asano Y
    Nihon Jinzo Gakkai Shi; 2003 Jul; 45(5):439-44. PubMed ID: 14509219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
    Edström Halling S; Söderberg MP; Berg UB
    Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological study of patients presenting hematuria and proteinuria by renal biopsy].
    Shinohara Y; Mitsui H; Nasu T; Hayashida S
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):72-9. PubMed ID: 2046202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
    Zhang Y; Wang F; Ding J; Zhang H; Liu X; Wang S; Xiao H; Yao Y; Liu J; Zhong X; Guan N; Su B; Wu G; Yu L
    Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.
    Sun LJ; Shan JP; Cui RL; Yuan WJ; Jiang GR
    Int Urol Nephrol; 2017 Jun; 49(6):1049-1056. PubMed ID: 28283858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of IgA nephropathy.
    Pozzi C
    J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
    Kim MJ; Song JH; Suh JH; Lee SW; Kim GA
    Yonsei Med J; 2003 Jun; 44(3):463-72. PubMed ID: 12833584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.